Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-amodiaquine for uncomplicated malaria in Burundi
PACTR201905610589889Phase 4Not yet recruiting
- Sponsor
- Ministère de la Santé Publique
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate and amodiaquine in malaria and Malaria, sponsored by Ministère de la Santé Publique. Primary endpoints: Early treatment failure, Late clinical failure and 2 more. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
artesunateamodiaquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on PACTR201905610589889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201905610589889.